Mark Dolev

2.1k citations

50 papers · 1.4k indexed · 1 hit paper · h-index 18

Impact in

Pathology and Forensic Medicine top 1%
- Multiple Sclerosis Research Studies
Neurology top 2%
- Peripheral Neuropathies and Disorders
- Long-Term Effects of COVID-19

Papers in

Pathology and Forensic Medicine 41
- Multiple Sclerosis Research Studies 40
Neurology 14
- Peripheral Neuropathies and Disorders 12
- Neuroinflammation and Neurodegeneration Mechanisms 4

Co-authors: Anat Achiron David Magalashvili Shay Menascu Michael Gurevich Yael Stern Uri Givon Alon Kalron Sapir Dreyer-Alster
Journals: PLoS ONE (5 papers)Multiple Sclerosis and Related Disorders (4 papers)Multiple Sclerosis Journal (3 papers)Journal of Neurology (3 papers)Therapeutic Advances in Neurological Disorders (3 papers)
Partner nations: Israel Switzerland Slovakia

In The Last Decade

Mark Dolev

50 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies 2021 · 235 citations

Peers

Countries citing papers authored by Mark Dolev

Since Specialization

Citations

This map shows the geographic impact of Mark Dolev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dolev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dolev more than expected).

Fields of papers citing papers by Mark Dolev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dolev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dolev. The network helps show where Mark Dolev may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Dolev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Dolev Line = papers co-authored together Mark Dolev links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Machine learning–based prediction of disease progression in primary progressive multiple sclerosis Brain Communications ·Michael Gurevich, Rina Zilkha‐Falb, J L Sherman, Maxime Usdin, Catarina Raposo, Licínio Craveiro, Polina Sonis, David Magalashvili, Shay Menascu, Mark Dolev, Anat Achiron	2024	1
2	Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis Multiple Sclerosis Journal - Experimental Translational and Clinical ·Shay Menascu, Michal Siegel-Kirshenbaum, Sapir Dreyer-Alster, Yehuda Warszawer, David Magalashvili, Mark Dolev, Mathilda Mandel, Gil Harari, Anat Achiron	2023	4
3	Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study PLoS ONE ·Gil Harari, Michael Gurevich, Mark Dolev, Rina Falb, Anat Achiron	2023	4
4	Radiological Disease Activity in Secondary Progressive Multiple Sclerosis European Neurology ·Daniela Noa Zohar, David Magalashvili, Sapir Dreyer-Alster, Chen Hoffmann, Gil Harari, Mark Dolev, Anat Achiron	2023	2
5	Longitudinal relationships between disability and gait characteristics in people with MS Scientific Reports ·Sapir Dreyer-Alster, Shay Menascu, Mark Dolev, Uri Givon, David Magalashvili, Anat Achiron, Alon Kalron	2022	6
6	Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a Journal of NeuroEngineering and Rehabilitation ·Shay Menascu, Roy Aloni, Mark Dolev, David Magalashvili, Keren Gutman, Sapir Dreyer-Alster, Franck Tarpin-Bernard, Ran Achiron, Gil Harari, Anat Achiron	2021	6
7	Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study Journal of Neuroimmunology ·Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, Mark Dolev, Shay Menascu, David Magalashvili, Shlomo Flechter, Uri Givon, Diana Guber, Polina Sonis, Rina Zilkha‐Falb, Michael Gurevich	2021	56
8	SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients International Journal of Infectious Diseases ·Michael Gurevich, Rina Zilkha‐Falb, Polina Sonis, David Magalashvili, Shay Menascu, Shlomo Flechter, Mark Dolev, Mathilda Mandel, Anat Achiron	2021	17
9	Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progression Multiple Sclerosis and Related Disorders ·Anat Achiron, Sapir Dreyer-Alster, Michael Gurevich, Shay Menascu, David Magalashvili, Mark Dolev, Yael Stern, Tomer Ziv‐Baran	2021	3
10	Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage Journal of the Neurological Sciences ·Shay Menascu, Aviva Fattal‐Valevski, Adi Vaknin‐Dembinsky, Ron Milo, Keren Geva, David Magalashvili, Mark Dolev, Shlomo Flecther, Alon Kalron, Shmulik Miron, Chen Hoffmann, Roy Aloni, Michael Gurevich, Anat Achiron	2021	6
11	The association between bladder dysfunction, balance and falls in women with multiple sclerosis: The specific contribution of fear of falling Gait & Posture ·Rotem Soll, Temima Greenberg, Mark Dolev, Alon Kalron	2021	3
12	Parity and disability progression in relapsing–remitting multiple sclerosis Journal of Neurology ·Anat Achiron, Alon Ben‐David, Michael Gurevich, David Magalashvili, Shay Menascu, Mark Dolev, Yael Stern, Tomer Ziv‐Baran, (unknown)	2020	12
13	The relationship between gait variability and cognitive functions differs between fallers and non-fallers in MS Journal of Neural Transmission ·Alon Kalron, Roy Aloni, Mark Dolev, Lior Frid, Uri Givon, Shay Menascu	2018	14
14	Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study PLoS ONE ·Anat Achiron, Joab Chapman, David Magalashvili, Mark Dolev, Mor Lavie, Eran Bercovich, Michael Polliack, Glen M. Doniger, Yael Stern, O. Khilkevich, Shay Menascu, Hararai Gil, Michael Gurevich, Yoram Barak	2013	119
15	Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis PLoS ONE ·Anat Achiron, Anna Feldman, David Magalashvili, Mark Dolev, Michael Gurevich	2012	20
16	Diffusion Tensor Imaging of Corpus Callosum Integrity in Multiple Sclerosis: Correlation with Disease Variables Journal of Neuroimaging ·Sigal Tal, Shmuel Miron, Mark Dolev, Gil Harari, Anat Achiron	2010	33
17	Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis Archives of Neurology ·Anat Achiron, I. Kishner, I Sarova-Pinhàs, H. Raz, Meir Faibel, Yael Stern, Mor Lavie, Michael Gurevich, Mark Dolev, David Magalashvili, Yoram Barak	2004	74
18	Understanding Autoimmune Mechanisms in Multiple Sclerosis Using Gene Expression Microarrays: Treatment Effect and Cytokine‐related Pathways Journal of Immunology Research ·Anat Achiron, Michael Gurevich, David Magalashvili, I. Kishner, Mark Dolev, M. Mandel	2004	22
19	Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis Journal of Neurology ·Anat Achiron, I. Kishner, Mark Dolev, Yael Stern, Mordechai Dulitzky, Eyal Schiff, R. Achiron	2004	141
20	Long-term morbidity and mortality after spinal cord injury: 50 years of follow-up Spinal Cord ·Gabi Zeilig, Mark Dolev, Harold Weingarden, Nava Blumen, Y Shemesh, A Ohry	2000	27

About Mark Dolev

Mark Dolev is a scholar working on Pathology and Forensic Medicine, Neurology, Neurology, Hematology and Orthopedics and Sports Medicine, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (40 papers), Peripheral Neuropathies and Disorders (12 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Effects of Vibration on Health (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.0k citations), Neurology (441 citations), Infectious Diseases (441 citations), Physical Therapy, Sports Therapy and Rehabilitation (53 citations) and Immunology (257 citations). Mark Dolev has collaborated with scholars based in Israel, Switzerland and Slovakia. Frequent co-authors include Anat Achiron, David Magalashvili, Shay Menascu, Michael Gurevich, Yael Stern, Uri Givon, Alon Kalron, Sapir Dreyer-Alster, Shlomo Flechter and Gil Harari. Their work appears in journals such as PLoS ONE, Multiple Sclerosis and Related Disorders, Multiple Sclerosis Journal, Journal of Neurology and Therapeutic Advances in Neurological Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact